Proof in Publications – The Most Cited. The Most Trusted. TriNetX Real-World Data.
Download the Infographic The Most Cited. The Most Trusted. TriNetX Real-World Data Leading the Way. TriNetX is the most cited EHR dataset in peer-reviewed publications. Cited more often, by more researchers, than our top competitors Outpacing the field by a wide...
Designing Clinical Trials for Diversity, Inclusion & Representativeness
How can clinical research move from talking about diversity to embedding representativeness as a foundation of trial design? In this episode of The Future Prescription: Inside the Trends, industry leaders explore how equitable design can transform science, improve...
TriNetX Named Among the Top 25 Healthcare Software Companies of 2025
Recognition by The Healthcare Technology Report underscores TriNetX’s innovation in real-world data, artificial intelligence, and clinical research transformation. CAMBRIDGE Mass., September 25, 2025 — TriNetX, the company behind the world’s broadest federated...
Putting Patients First: A Conversation with Ora on the Future of Clinical Trials
In my role at TriNetX, I have the privilege of engaging with leaders across the clinical research landscape who are challenging the status quo and pushing us toward a more inclusive, tech-enabled, and patient-first future. One of the most rewarding conversations I’ve...
Care Reimagined: The Shift Toward Patient-Centric Research
What happens when clinical research is redesigned around the needs, preferences, and lives of real people? In this episode of The Future Prescription: Inside the Trends, discover how sponsors and CROs are aligning clinical and commercial priorities to create smarter,...
Inclusion Is the New Standard: Biopharma’s Push for More Representative Clinical Trials
As clinical trials evolve, one thing is certain: representativeness is no longer a nice-to-have; it’s a non-negotiable. The data are clear. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, 84% reported ramping up efforts to improve...
ISPE to Impact: Shaping the Next Era of Pharmacoepidemiology with Real-World Data
Reflecting on the discussions from this year’s International Society for Pharmacoepidemiology (ISPE) Annual Meeting and looking ahead to the future of the field, I’m struck by the steady but significant evolution pharmacoepidemiology is undergoing driven in large part...
From Buzz to Breakthrough: How Biopharma Is Embedding Real-World Data into Drug Development
In just a few years, real-world data (RWD) has evolved from an industry buzzword to a core driver of progress in drug development. What used to be experimental is now operational and increasingly essential. In the 2025 TriNetX and studioID survey of 150 senior...